Particle.news
Download on the App Store
8 ARTICLES
·
2w ago

NHS Begins Mounjaro Rollout in Primary Care as Regulators Review Safety

GPs will start prescribing weekly injections to the highest-need patient groups in June through a phased plan that allows regulators to monitor safety

Image
Image
Image
Image

Overview

  • Under NHS guidance Mounjaro is approved for adults with a BMI over 30 or a BMI over 27 with weight-related health complications.
  • Patients are divided into three cohorts based on BMI and comorbidities to prioritise access over the next three years.
  • Regulators are investigating more than 100 reported deaths linked to GLP-1 drugs including Mounjaro, though no direct causal link has been confirmed.
  • Mounjaro works by mimicking gut hormones to curb hunger and slow gastric emptying to aid sustained weight loss.
  • Users like Glasgow mother Sarah Hill have reported rapid weight loss and manageable side effects with specialist support.